27 results on '"Simpson, Mindy L."'
Search Results
2. Hemophilia: A Review of Perioperative Management for Cardiac Surgery
3. Outcomes of a Vial-Sparing Antithrombin III Protocol in Pediatric Extracorporeal Membrane Oxygenation
4. Effects of PK‐guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A
5. Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY 94-9027 for Severe Haemophilia A: A Post Hoc Analysis
6. Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial
7. Recognition and Management of Hemophilia Emergencies
8. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults
9. Role of global assays in thrombosis and thrombophilia
10. Using an educational intervention to assess and improve disease‐specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B
11. Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis
12. Fibrinogen Replacement Underutilization in ECMO
13. Improved Bleeding Outcomes in Patients Who Switched From Sucrose-Formulated rFVIII to BAY 94-9027 Prophylaxis in PROTECT VIII
14. U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association between Family History and Age of Diagnosis
15. A Real-World Analysis of Commonly Prescribed FVIII Products Based on U.S. Medical Charts: Consumption and Bleeding Outcomes in Hemophilia A Patients
16. The Authors Respond
17. Non-Genetic Risk Factors for Inhibitor Development
18. Management of joint bleeding in hemophilia
19. Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products
20. Population Pharmacokinetic Modeling Of On-Demand And Surgical Use Of Nonacog Beta Pegol (N9-GP) And rFIXFc Based Upon The paradigm 7 Comparative Pharmacokinetic Study
21. Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis.
22. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors
23. Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight
24. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors
25. Vitamin D Deficiency and Osteoporosis In Hemophilia: An Underappreciated Risk
26. Developing Infrastructure For International Collaborative Research In Coagulation Disorders: Coagulation Disorders Research Consortium (CDRC) and Coagulation Disorders Data and Specimen Repository (Biorepository)
27. Biologic Response and Adverse Events To Stimate In Patients With Von Willebrand Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.